Remote Monitoring and Home-based Health Care for Treatment o... | Clinical Trial | StuddyBuddy@endsection Remote Monitoring and Home-based Health Care for Treatment of Bone Marrow Transplant Patients
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05662631

Remote Monitoring and Home-based Health Care for Treatment of Bone Marrow Transplant Patients

Conditions: Bone Marrow Transplant

Sex: All
Ages: 18 Years – 89 Years
Phase: NA
Enrollment: 10
Sponsor: University of Colorado, Denver

Location: United States

Summary

This study is designed to assess the potential for successfully using technology-assisted in-home oncology care, including remote patient monitoring (RPM), telemedicine, and home-based health care services to support improved care management and appropriate referral to treatment for bone marrow transplant (BMT) patients.

Eligibility Criteria

Inclusion Criteria:Age 18 years to 89 years oldBone marrow transplant recipients (allogeneic)Determined by care provider to be stable for discharge to home setting for outpatient care according to clinical practice standard operating procedures (SOPs)Residing in the Denver metro area for the duration of the study within 45 minutes of the AMCHas in-home caregiver support 24/7 (i.e., does not live alone)Has reliable telephone and home internet service and stable wireless networkPatient has agreed to not submerge the BioSticker device in more than 3 feet of water or submerge for longer than 30 minutes at a time.Patient owns or possesses, as the primary user with reliable daily access, a mobile device (iOS or Android) capable of running the study's mobile application and accepting the terms and conditionsPatient is willing to complete a self-check temperature log to comply and be available for the duration of the studyHas access to reliable transportation to the hospital 24/7Exclusion Criteria:Patients will be excluded from study participation if the PI or designated care provider believes study participation would not be in the patient's best interest for clinical reasons.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05662631). StuddyBuddy aggregates publicly available trial information.